Delivery Order SPE2DE21D0017-SPE2D625F3SYL
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on September 5, 2025, for COVID-19 test kits valued at $15,000.00 with a completion date of September 16, 2025. This fixed-price contract with economic price adjustment clauses was awarded without set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain funded this award, and performance will be completed in Lockhart, Florida. The delivery order...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on April 28, 2025, for COVID-19 test kits with a ceiling value of $2,400.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of May 7, 2025, and will be performed in Lockhart, Florida. The contract was awarded without a set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain, operating under...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $3,600.00 on September 9, 2025, for COVID-19 test kits under contract 4569386625. The contract utilizes fixed-price pricing with economic price adjustment and has an ultimate completion date of September 18, 2025. Performance will occur in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. The funding source is the Defense...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on July 14, 2025, for COVID-19 test kits under contract number 4568782066. The contract is a fixed-price delivery order with economic price adjustment provisions and will be performed in Lockhart, Florida, with an ultimate completion date of July 23, 2025. The award was made without set-aside designation, indicating open competition. Funding is provided through the...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order contract valued at $6,000 for COVID-19 test kits by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on September 16, 2025, with an ultimate completion date of September 25, 2025, utilizes a fixed-price structure with economic price adjustment provisions and was awarded without a set-aside designation, indicating full and open competition. Performance of this...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment for COVID-19 test kits on August 7, 2025, with an ultimate completion date of August 18, 2025. The contract, issued without set-aside designation, is funded by the Defense Logistics Agency Medical Supply Chain and specifies performance at the contractor's facility in Lockhart, Florida. This delivery order represents a continuation of...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on September 18, 2025, for COVID-19 test kits to support the Defense Logistics Agency Medical Supply Chain. The contract, designated as a fixed-price agreement with economic price adjustment provisions, carries an ultimate completion date of September 29, 2025, and will be performed in Lockhart, Florida. No set-aside designation was applied to this award, indicating the...
- The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a $3.55 million delivery order contract to provide COVID-19 test kits. The fixed-price with economic price adjustment contract has a period of performance from August 30, 2023 to September 11, 2023, with delivery of the test kits to take place in Lockhart, Florida. Abbott Rapid DX North America LLC will fulfill the agency's requirement for COVID-19 testing as it...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $12,720.00 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain on October 15, 2025, with an ultimate completion date of October 21, 2025. The contract, which carries no set-aside designation and indicates open competition, is for a kit identification, now strip A2 qualification detector mobile/mobile laboratory test. Performance will occur in...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,328.00 fixed-price delivery order contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide COVID-19 test kits. The contract has an ultimate completion date of November 22, 2024. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, to federal agencies like the Department of Veterans Affairs (VA) and Department of...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D625F3SYLDelivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on September 17, 2025, for COVID-19 diagnostic test kits under contract 4569502136. The order, valued at $3,600.00 with a fixed-price contract type that includes economic price adjustment provisions, is scheduled for completion by September 26, 2025. The products will be delivered to Lockhart, Florida, and the award was made by the Defense Logistics Agency Medical Supply Chain without a set-aside designation, indicating open competition. This delivery order represents a continuation of Abbott Rapid DX North America LLC's established role as a critical supplier of diagnostic testing products to federal healthcare agencies. The award supports ongoing federal testing and diagnostic needs across defense healthcare facilities. Abbott Rapid DX North America LLC maintains an extensive portfolio of federal contracts, including multiple Blanket Purchase Agreements and Indefinite Delivery contracts with the Department of Veterans Affairs across various regional networks, focusing primarily on COVID-19 antigen test kits, point-of-care testing devices, and related diagnostic supplies. The company's consistent selection for these procurements reflects its established capabilities in providing advanced medical testing technologies and its position as a key vendor within the federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/17/25 |